The significantly increased production of IL‐10 by S‐specific CD8+ T cells in diabetes groups, potentially detrimental for an optimal vaccine‐specific T cell response, prompted us to examine its pattern of expression further, and we explored the possibility of a CD8+ T cell regulatory population arising in diabetes characterized by IL‐10 expression. This evidence concerns the gene CD8A and diabetes mellitus.